Mesalazine-induced lupus syndrome

Gunnarsson I , Kanerud L , Pettersson E , et al. Predisposing factors in sulphasalazine-induced systemic lupus erythematosus . Br J Rheum 1997; 36: 1089–1094 .

Gunnarsson I , Pettersson E , Lindblad S , Ringertz B . Olsalazineinduced lupus syndrome . Scand J Rheumatol 1997; 26: 65–66 .

Dent M , Ganapathy S , Holdsworth C , Channer K . Mesalazine induced lupus-like syndrome . BMJ 1992; 305: 159-159 .

Lim A , Hine K. Fever , vasculitic rash , arthritis , pericarditis , and pericardial effusion after mesalazine . BMJ 1994; 308: 113-113 .

Waanders H , Thompson J . Kawasaki-like syndrome after treatment with mesalazine . Am J Gastroenterol 1991; 86: 219–221 .

Jenss H , Becker E , Weber P . Pericardial effusion during treatment with 5-amino-salicylic acid in a patient with Crohn's disease . Am J Gastroenterol 1990; 85: 332–333 .

Timsit M , Anglicheau D , Liote F et al. Mesalazine-induced lupus . Rev Rheum Engl Ed 1997; 64: 586–588 .

Tan E , Cohen A , Fries J et al. The 1982 revised criteria for the classification of systemic lupus erythematosus . Arthritis Rheum 1982; 25: 1271–1277 .

Danzé P-M , Colombel J-F , Jacquoat S et al. Association of HLA class II genes with susceptibility to Crohn's disease . Gut 1996; 39: 69–72 .

Reinshagen M , Loeliger C , Kuehnl P et al. HLA class II gene frequencies in Crohn's disease: a population based analysis in Germany . Gut 1996; 38: 538–542 .

Skarsvåg S , Hansen K , Holst A , Moen T . Distribution of HLA class II alleles among Scandinavian patients with systemic lupus erythematosus (SLE): An increased risk of SLE among non-(DRB1*03,DQA1*0501,DQB1*0201) class II homozygotes . Tissue Antigens 1992; 40: 128–133 .

Nagata M , Ogawa Y , Hisano S , Ueda K . Crohn's disease in systemic lupus erythematosus: a case report . Eur J Pediatr 1989; 148: 525–526 .

Johnson D , Diehl A , Finkelman F , Cattau E . Crohn's disease and systemic lupus erythematosus . Am J Gastroenterol 1985; 80: 869–870 .